Charise Gleason
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 5%
- Neutropenia and Cancer Infections
- Peptidase Inhibition and Analysis
Papers in
- Hematology 36
- Multiple Myeloma Research and Treatments 35
-
- Protein Degradation and Inhibitors 22
- Histone Deacetylase Inhibitors Research 5
- Co-authors
- Amelia Langston (11 shared papers)Christopher R. Flowers (6 shared papers)Eric J. Bow (3 shared papers)Douglas K. Hawley (3 shared papers)Kenneth V. I. Rolston (3 shared papers)Sagar Lonial (35 shared papers)Jonathan L. Kaufman (30 shared papers)Erin B. Kennedy (2 shared papers)
- Journals
- Blood (16 papers)Journal of Clinical Oncology (7 papers)Cancer (4 papers)Current Hematologic Malignancy Reports (2 papers)Blood Cancer Journal (1 paper)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Charise Gleason
41 papers receiving 1.5k citations
Charise Gleason's Hit Papers
Peers
Comparison fields: 5 of 74
- Hematology 596
- Oncology 834
- Clinical Biochemistry 111
- Emergency Medicine 71
- Genetics 84
Countries citing papers authored by Charise Gleason
This map shows the geographic impact of Charise Gleason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charise Gleason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charise Gleason more than expected).
Fields of papers citing papers by Charise Gleason
This network shows the impact of papers produced by Charise Gleason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charise Gleason. The network helps show where Charise Gleason may publish in the future.
Co-authors
The 25 scholars most cited alongside Charise Gleason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Hit paper breakdown → | 2018 | 376 |
| 2 | 2013 | 309 | |
| 3 | 2018 | 223 | |
| 4 | 2013 | 143 | |
| 5 | 2011 | 85 | |
| 6 | 2019 | 65 | |
| 7 | 2019 | 44 | |
| 8 | 2018 | 34 | |
| 9 | 2013 | 27 | |
| 10 | 2010 | 27 | |
| 11 | 2018 | 27 | |
| 12 | 2014 | 20 | |
| 13 | 2016 | 20 | |
| 14 | 2020 | 19 | |
| 15 | 2012 | 15 | |
| 16 | 2014 | 10 | |
| 17 | 2018 | 9 | |
| 18 | 2018 | 8 | |
| 19 | 2011 | 7 | |
| 20 | 2007 | 7 |
About Charise Gleason
Charise Gleason is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Infectious Diseases, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (35 papers), Protein Degradation and Inhibitors (22 papers), Cancer Treatment and Pharmacology (12 papers), Peptidase Inhibition and Analysis (8 papers), Histone Deacetylase Inhibitors Research (5 papers), Neutropenia and Cancer Infections (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Hematology (596 citations), Oncology (834 citations), Clinical Biochemistry (111 citations), Emergency Medicine (71 citations) and Genetics (84 citations). Charise Gleason has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Amelia Langston, Christopher R. Flowers, Eric J. Bow, Douglas K. Hawley, Kenneth V. I. Rolston, Sagar Lonial, Jonathan L. Kaufman, Erin B. Kennedy, Lynne Strasfeld and Loretta J. Nastoupil. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Current Hematologic Malignancy Reports and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.